Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression

Virology. 2006 Mar 1;346(1):15-31. doi: 10.1016/j.virol.2005.09.065. Epub 2005 Nov 21.

Abstract

Infection of fibroblasts by human cytomegalovirus (HCMV) rapidly activates the NF-kappaB signaling pathway, which we documented promotes efficient transactivation of the major immediate-early promoter (DeMeritt, I.B., Milford, L.E., Yurochko, A.D. (2004). Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J. Virol. 78, 4498-4507). Because a second, sustained increase in NF-kappaB activity following the initial phase of NF-kappaB activation was also observed, we investigated the role that this prolonged NF-kappaB activation played in viral replication and late gene expression. We first investigated HCMV replication in cells in which NF-kappaB activation was blocked by pretreatment with NF-kappaB inhibitors: HCMV replication was significantly decreased in these cultures. A decrease in replication was also observed when NF-kappaB was inhibited up to 48 h post-infection, suggesting a previously unidentified role for NF-kappaB in the regulation of the later class of viral genes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspirin / pharmacology
  • Cells, Cultured
  • Cytomegalovirus / metabolism
  • Cytomegalovirus / pathogenicity
  • Cytomegalovirus / physiology*
  • Fibroblasts
  • Gene Expression Regulation, Viral*
  • Humans
  • Leupeptins / pharmacology
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism*
  • Time Factors
  • Viral Proteins / genetics
  • Viral Proteins / metabolism*
  • Virus Replication*

Substances

  • Leupeptins
  • NF-kappa B
  • Viral Proteins
  • Aspirin
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde